337 related articles for article (PubMed ID: 32173005)
1. Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy.
Munger KC; Samkoff LM
Mult Scler Relat Disord; 2020 Jan; 37():101442. PubMed ID: 32173005
[TBL] [Abstract][Full Text] [Related]
2. Gaze palsy, hypogeusia and a probable association with miscarriage of pregnancy--the expanding clinical spectrum of non-opticospinal neuromyelitis optica spectrum disorders: a case report.
Chang T; Withana M
BMC Res Notes; 2015 Feb; 8():36. PubMed ID: 25888897
[TBL] [Abstract][Full Text] [Related]
3. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
[TBL] [Abstract][Full Text] [Related]
4. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
5. Different clinical phenotypes of AQP4-IgG positive NMOSD in two first degree relatives.
Ssemmanda S; Musubire AK
BMC Neurol; 2023 Sep; 23(1):315. PubMed ID: 37667215
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
Aungsumart S; Apiwattanakul M
Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
[TBL] [Abstract][Full Text] [Related]
7. Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab.
Shidahara K; Hayashi K; Sada KE; Hiramatsu S; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Jul; 27(8):1374-1377. PubMed ID: 29498304
[TBL] [Abstract][Full Text] [Related]
8. A Case Report of NMO Transverse Myelitis.
Lafian A; Mahani T; Hojjati M; Sarlati T
Curr Rheumatol Rev; 2024; 20(2):208-212. PubMed ID: 37861018
[TBL] [Abstract][Full Text] [Related]
9. Individualized B cell-targeting therapy for neuromyelitis optica spectrum disorder.
Kim SH; Hyun JW; Kim HJ
Neurochem Int; 2019 Nov; 130():104347. PubMed ID: 30513364
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
11. Longitudinally extensive transverse myelitis with positive aquaporin-4 IgG associated with dengue infection: a case report and systematic review of cases.
Comtois J; Camara-Lemarroy CR; Mah JK; Kuhn S; Curtis C; Braun MH; Tellier R; Burton JM
Mult Scler Relat Disord; 2021 Oct; 55():103206. PubMed ID: 34418736
[TBL] [Abstract][Full Text] [Related]
12. Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
Hyun JW; Kim G; Kim Y; Jeong IH; Kim SH; Kim HJ
Neurologist; 2016 Nov; 21(6):97-98. PubMed ID: 27801768
[TBL] [Abstract][Full Text] [Related]
13. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.
Carnero Contentti E; Hryb JP; Morales S; Gomez A; Chiganer E; Di Pace JL; Lessa C; Perassolo M
J Neurol Sci; 2017 Feb; 373():134-137. PubMed ID: 28131170
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica spectrum disorder and systemic lupus erythematosus.
Thabah MM; D S; Pranov R; Moulitej MMV; Ramesh A; Kadhiravan T
Lupus; 2019 Dec; 28(14):1722-1726. PubMed ID: 31722604
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
16. Intractable nausea and vomiting as an uncommon presentation in an anti-aquaporin 4-positive patient.
Wang L; Su HJ; Qi JL; E RF; Zhao K
J Int Med Res; 2018 Aug; 46(8):3411-3416. PubMed ID: 29806512
[TBL] [Abstract][Full Text] [Related]
17. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F
Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766
[TBL] [Abstract][Full Text] [Related]
19. ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Dai Y; Ni S; Wu F; Guo S; Zhao X; Wang J
J Clin Pharm Ther; 2022 Sep; 47(9):1379-1387. PubMed ID: 35488449
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]